PMC:7796052 / 5668-5864 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7796052","sourcedb":"PMC","sourceid":"7796052","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7796052","text":"Moreover, the compound showed a weak partial agonist profile with a maximal activity of ~20%. Ralixofene is a selective estrogen receptor modulator, exerting estrogen agonist action in some target","tracks":[{"project":"LitCovid-PubTator","denotations":[{"id":"163","span":{"begin":120,"end":137},"obj":"Gene"},{"id":"179","span":{"begin":94,"end":104},"obj":"Chemical"}],"attributes":[{"id":"A163","pred":"tao:has_database_id","subj":"163","obj":"Gene:2099"},{"subj":"163","pred":"source","obj":"LitCovid-PubTator"},{"subj":"179","pred":"source","obj":"LitCovid-PubTator"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}]},{"project":"LitCovid-sentences","denotations":[{"id":"T37","span":{"begin":0,"end":93},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T37","pred":"source","obj":"LitCovid-sentences"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PubTator","color":"#93d3ec","default":true},{"id":"LitCovid-sentences","color":"#eceb93"}]}]}}